[Biguanides in oral antidiabetic therapy: indications and limitations].
Gregorio
F
F
Filipponi
P
P
D000284:Administration, Oral; D001645:Biguanides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002026:Buformin / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use; D010629:Phenformin / Q000627:therapeutic use
D001645:Biguanides; D007004:Hypoglycemic Agents; D008687:Metformin; D010629:Phenformin; D002026:Buformin
Le biguanidi nella terapia antidiabetica orale: indicazioni e limiti.